Screening mild and major neurocognitive disorders in Parkinson's disease

Behavioural Neurology

Volumn 2015, Issue , 2015, Pages

  Lucza, Tivadar ^a   Karádi, Kázmér ^a   Kállai, János ^a   Weintraut, Rita ^a   Janszky, József ^a   Makkos, Attila ^a   Komoly, Sámuel ^a   Kovács, Norbert ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ADDENBROOKE COGNITIVE EXAMINATION; ADULT; AGED; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; DSM-5; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MATTIS DEMENTIA RATING SCALE; MIDDLE AGED; MINI MENTAL STATE EXAMINATION; MONTREAL COGNITIVE ASSESSMENT; NEUROPSYCHOLOGICAL TEST; PARKINSON DISEASE; PREDICTIVE VALUE; PRIORITY JOURNAL; RATING SCALE; SCREENING TEST; SENSITIVITY AND SPECIFICITY; COGNITIVE DYSFUNCTION; COMPLICATION; DEMENTIA; DEPRESSION; PROCEDURES; PSYCHOLOGY; PSYCHOMETRY;

COGNITIVE DYSFUNCTION; DEMENTIA; DEPRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; PSYCHOMETRICS;

EID: 84930645861     PISSN: 09534180     EISSN: 18758584     Source Type: Journal    
DOI: 10.1155/2015/983606     Document Type: Article

References (65)

1. W.G. Reid, "The evolution of dementia inidiopathic Parkinson's disease: neuropsychological and clinical evidence in support of subtypes," International Psychogeriatrics, vol. 4, supplement 2, pp. 147-160, 1992.
2. A. I. Tröster, S. P. Woods, and E. E. Morgan, "Assessing cognitive change in Parkinson's disease: development of practice efect-corrected reliable change indices," Archives of Clinical Neuropsy-chology, vol. 22, no. 6, pp. 711-718, 2007.
3. J. Kulisevsky and J. Pagonabarraga, "Cognitive impairment in Parkinson's disease: tools for diagnosis and assessment," Movement Disorders, vol. 24, no. 8, pp. 1103-1110, 2009.
4. K. Dujardin, A. Duhamel, M. Delliaux, C. Tomas-Antérion, A. Destée, and L. Defebvre, "Cognitive complaints in Parkinson's disease: its relationship with objective cognitive decline," Journal of Neurology, vol. 257, no. 1, pp. 79-84, 2010.
5. W. G. J. Reid, M. A. Hely, J. G. L. Morris, C. Loy, and G. M. Halliday, "Dementia in Parkinson's disease: a 20-year neuropsychological study (Sydney multicentre study)," Journal of Neurology, Neurosurgery and Psychiatry, vol. 82, no. 9, pp. 1033-1037, 2011.
6. M. A. Hely, W. G. J. Reid, M. A. Adena, G. M. Halliday, and J. G. L. Morris, "The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years," Movement Disorders, vol. 23, no. 6, pp. 837-844, 2008.
7. K. Marder, "Cognitive impairment and dementia in Parkinson's disease," Movement Disorders, vol. 25, no. 1, pp. S110-S116, 2010.
8. D. Aarsland, K. Andersen, J. P. Larsen, A. Lolk, and P. Kragh-Sørensen, "Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study," Archives of Neurology, vol. 60, no. 3, pp. 387-392, 2003.
9. C. G. Goetz, M. Emre, and B. Dubois, "Parkinson's disease dementia: defnitions, guidelines, and research perspectives in diagnosis," Annals of Neurology, vol. 64, supplement 2, pp. S81-S92, 2008.
10. G. J. Geurtsen, J. Hoogland, J. G. Goldman et al., "Parkinson's disease mild cognitive impairment: application and validation of the criteria," Journal of Parkinson's Disease, vol. 4, no. 2, pp. 131-137, 2014.
11. I. Litvan, J. G. Goldman, A. I. Tröster et al., "Diagnostic criteria for mild cognitive impairment in Parkinson's disease: movement disorder society task force guidelines," Movement Disorders, vol. 27, no. 3, pp. 349-356, 2012.
12. I. Litvan, D. Aarsland, C. H. Adler et al., "MDS task force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI," Movement Disorders, vol. 26, no. 10, pp. 1814-1824, 2011.
13. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, American Psychiatric Publishing, Arlington, Va, USA, 2013.
14. B. Kaszás, N. Kovács, I. Balás et al., "Sensitivity and specifcity of Addenbrooke's Cognitive Examination, Mattis Dementia Rating Scale, Frontal Assessment Battery and Mini Mental State Examination for diagnosing dementia in Parkinson's disease," Parkinsonism and Related Disorders, vol. 18, no. 5, pp. 553-556, 2012.
15. G. Fehér, I. Balás, S. Komoly et al., "Analysis of antiparkinsonian drug reduction afer bilateral subthalamic deep brain stimulation," Ideggyogyaszati Szemle, vol. 63, no. 9-10, pp. 314-319, 2010.
16. A. Égerházi, "The early diagnosis and diferential diagnosis of Alzheimer's disease with clinical methods," Orvosi Hetilap, vol. 149, no. 51, pp. 2433-2440, 2008.
17. M. F. Folstein, S. E. Folstein, and P. R. McHugh, "'Mini-mental state': a practical method for grading the cognitive state of patients for the clinician," Journal of Psychiatric Research, vol. 12, no. 3, pp. 189-198, 1975.
18. T. N. Tombaugh and N. J. McIntyre, "The mini-mental state examination: a comprehensive review," Journal of the American Geriatrics Society, vol. 40, no. 9, pp. 922-935, 1992.
19. E. P. Feher, R. K. Mahurin, R. S. Doody, N. Cooke, J. Sims, and F. J. Pirozzolo, "Establishing the limits of the mini-mental state: examination of 'subtests'," Archives of Neurology, vol. 49, no. 1, pp. 87-92, 1992.
20. K. S. Santacruz and D. Swagerty, "Early diagnosis of dementia," The American Family Physician, vol. 63, no. 4, pp. 703-717, 2001.
21. E. Magloczky and Z. Janka, "Assessment of dementia in social welfare homes: applicability of the mini-mental state test," Szociális Gondozó, vol. 1, pp. 76-87, 1988.
22. K. L. Chou, M. M. Amick, J. Brandt et al., "A recommended scale for cognitive screening in clinical trials of Parkinson's disease," Movement Disorders, vol. 25, no. 15, pp. 2501-2507, 2010.
23. C. Marras, M. J. Armstrong, C. A. Meaney et al., "Measuring mild cognitive impairment in patients with Parkinson's disease," Movement Disorders, vol. 28, no. 5, pp. 626-633, 2013.
24. P. S. Mathuranath, P. J. Nestor, G. E. Berrios, W. Rakowicz, and J. R. Hodges, "A brief cognitive test battery to diferentiate Alzheimer's disease and frontotemporal dementia," Neurology, vol. 55, no. 11, pp. 1613-1620, 2000.
25. M. A. Reyes, S. P. Lloret, E. R. Gerscovich, M. E. Martin, R. Leiguarda, and M. Merello, "Addenbrooke's Cognitive examination validation in Parkinson's disease," European Journal of Neurology, vol. 16, no. 1, pp. 142-147, 2009.
26. N. C. Komadina, Z. Terpening, Y. Huang, G. M. Halliday, S. L. Naismith, and S. J. G. Lewis, "Utility and limitations of Addenbrooke's cognitive examination-revised for detecting mild cognitive impairment in Parkinson's disease," Dementia and Geriatric Cognitive Disorders, vol. 31, no. 5, pp. 349-357, 2011.
27. P. Mccolgan, J. R. Evans, D. P. Breen, S. L. Mason, R. A. Barker, and C. H. Williams-Gray, "Addenbrooke's Cognitive Examination-Revised for mild cognitive impairment in Parkinson's disease," Movement Disorders, vol. 27, no. 9, pp. 1173-1177, 2012.
28. S. Mattis, "Mental status examination for organic mental syndrome in the elderly patient," in Geriatric Psychiatry, L. Bellack and T. B. Karusu, Eds., pp. 77-121, Grune & Stratton, New York, NY, USA, 1976.
29. G. G. Brown, A. Armstrong Rahill, J. M. Gorell et al., "Validity of the dementia rating scale in assessing cognitive function in Parkinson's disease," Journal of Geriatric Psychiatry and Neurology, vol. 12, no. 4, pp. 180-188, 1999.
30. G. Llebaria, J. Pagonabarraga, J. Kulisevsky et al., "Cut-of score of the Mattis Dementia Rating Scale for screening dementia in Parkinson's disease," Movement Disorders, vol. 23, no. 11, pp. 1546-1550, 2008.
31. G. Deli, Z. Aschermann, P. Acs et al., "Bilateral subthalamic stimulation can improve sleep quality in Parkinson's disease," Journal of Parkinson's Disease. In press.
32. B. Dubois, D. Burn, C. Goetz et al., "Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force," Movement Disorders, vol. 22, no. 16, pp. 2314-2324, 2007.
33. G. Di Virgilio, A. Leroy, P. Cunin, F. Mahieux, A. Bachoud-Levi, and G. Fenelon, "The Mini Mental Parkinson brief cognitive test: comparison with the Mattis dementia rating scale in 289 patients with Parkinson's disease," Movement Disorder, vol. 22, p. S90, 2007.
34. Z. S. Nasreddine, N. A. Phillips, V. Bédirian et al., "The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment," Journal of the American Geriatrics Society, vol. 53, no. 4, pp. 695-699, 2005.
35. D. J. Gill, A. Freshman, J. A. Blender, and B. Ravina, "The Montreal Cognitive Assessment as a screening tool for cognitive impairment in Parkinson's disease," Movement Disorders, vol. 23, no. 7, pp. 1043-1046, 2008.
36. S. Hoops, S. Nazem, A. D. Siderowf et al., "Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease," Neurology, vol. 73, no. 21, pp. 1738-1745, 2009.
37. J. C. Dalrymple-Alford, M. R. MacAskill, C. T. Nakas et al., "The MoCA: well-suited screen for cognitive impairment in Parkinson disease," Neurology, vol. 75, no. 19, pp. 1717-1725, 2010.
38. P. Julayanont, M. Brousseau, H. Chertkow, N. Phillips, and Z. S. Nasreddine, "Montreal Cognitive Assessment Memory Index Score (MoCA-MIS) as a predictor of conversion from mild cognitive impairment to Alzheimer's disease," Journal of the American Geriatrics Society, vol. 62, no. 4, pp. 679-684, 2014.
39. S. Nazem, A. D. Siderowf, J. E. Duda et al., "Montreal cognitive assessment performance in patients with Parkinson's disease with 'normal' global cognition according to mini-mental state examination score," Journal of the American Geriatrics Society, vol. 57, no. 2, pp. 304-308, 2009.
40. A. J. Larner, "Comparing diagnostic accuracy of cognitive screening instruments: a weighted comparison approach," Dementia and Geriatric Cognitive Disorders Extra, vol. 3, no. 1, pp. 60-65, 2013.
41. C.-F. Tsai, W.-J. Lee, S.-J. Wang, B.-C. Shia, Z. Nasreddine, and J.-L. Fuh, "Psychometrics of the Montreal Cognitive Assessment (MoCA) and its subscales: validation of the Taiwanese version of the MoCA and an item response theory analysis," International Psychogeriatrics, vol. 24, no. 4, pp. 651-658, 2012.
42. Y. Fujiwara, H. Suzuki, M. Yasunaga et al., "Brief screening tool for mild cognitive impairment in older Japanese: validation of the Japanese version of the Montreal Cognitive Assessment," Geriatrics and Gerontology International, vol. 10, no. 3, pp. 225-232, 2010.
43. A. Wong, Y. Y. Xiong, P. W. L. Kwan et al., "The validity, reliability and clinical utility of the Hong Kong Montreal Cognitive Assessment (HK-MoCA) in patients with cerebral small vessel disease," Dementia and Geriatric Cognitive Disorders, vol. 28, no. 1, pp. 81-87, 2009.
44. M. Volosin, K. Janacsek, and D. Németh, "Hungarian version of the Montreal Cognitive Assessment (MoCA) for screening mild cognitive impairment," Psychiatria Hungarica, vol. 28, no. 4, pp. 370-392, 2013.
45. A. S. Costa, B. Fimm, P. Friesen et al., "Alternate-form reliability of the montreal cognitive assessment screening test in a clinical setting," Dementia and Geriatric Cognitive Disorders, vol. 33, no. 6, pp. 379-384, 2012.
46. A. S. Costa, A. Reich, B. Fimm, S. T. Ketteler, J. B. Schulz, and K. Reetz, "Evidence of the sensitivity of the MoCA alternate forms in monitoring cognitive change in early alzheimer's disease," Dementia and Geriatric Cognitive Disorders, vol. 37, no. 1-2, pp. 95-103, 2014.
47. I. Litvan, K. P. Bhatia, D. J. Burn et al., "SIC task force appraisal of clinical diagnostic criteria for parkinsonian disorders," Movement Disorders, vol. 18, no. 5, pp. 467-486, 2003.
48. L. B. Zahodne, S. Young, L. Kirsch-Darrow et al., "Examination of the Lille Apathy Rating Scale in Parkinson disease," Movement Disorders, vol. 24, no. 5, pp. 677-683, 2009.
49. S. A. Montgomery and M. Asberg, "A new depression scale designed to be sensitive to change," British Journal of Psychiatry, vol. 134, no. 4, pp. 382-389, 1979.
50. L. Stacho, R. Dudás, R. Ivady, G. Kothencz, and Z. Janka, "Addenbrooke's cognitive examination: developing the hungarian version," Psychiatria Hungarica, vol. 18, pp. 226-240, 2003.
51. M. M. Hoehn and M. D. Yahr, "Parkinsonism: onset, progression and mortality," Neurology, vol. 17, no. 5, pp. 427-442, 1967.
52. K. Horváth, Z. Aschermann, P. Ács et al., "Validation of the Hungarian MDS-UPDRS: why do we need a new Parkinson scale?" Ideggyogyaszati Szemle, vol. 67, no. 3-4, pp. 129-134, 2014.
53. K. Horváth, Z. Aschermann, P. Á cs et al., "Is the MDS-UPDRS a good screening tool for detecting sleep problems and daytime sleepiness in Parkinson's disease?" Parkinson's Disease, vol. 2014, Article ID 806169, 8 pages, 2014.
54. R. Core Team, R: A Language and Environment for Statistical Computing, R Foundation for Statistical Computing, Vienna, Austria, 2015.
55. X. Robin, N. Turck, A. Hainard et al., "pROC: an open-source package for R and S+ to analyze and compare ROC curves," BMC Bioinformatics, vol. 12, article 77, 2011.
56. J. B. Anang, J. F. Gagnon, J. A. Bertrand et al., "Predictors of dementia in Parkinson disease: a prospective cohort study," Neurology, vol. 83, no. 14, pp. 1253-1260, 2014.
57. S. Villeneuve, J. Rodrigues-Brazète, S. Joncas, R. B. Postuma, V. Latreille, and J. F. Gagnon, "Validity of the Mattis Dementia rating scale to detect mild cognitive impairment in Parkinson's disease and REM sleep behavior disorder," Dementia and Geriatric Cognitive Disorders, vol. 31, no. 3, pp. 210-217, 2011.
58. E. Pirogovsky, D. M. Schiehser, I. Litvan et al., "The utility of the Mattis Dementia Rating Scale in Parkinson's disease mild cognitive impairment," Parkinsonism and Related Disorders, vol. 20, no. 6, pp. 627-631, 2014.
59. I. van Steenoven, D. Aarsland, H. Hurtig et al., "Conversion between mini-mental state examination, montreal cognitive assessment, and dementia rating scale-2 scores in Parkinson's disease," Movement Disorders, vol. 29, no. 14, pp. 1809-1815, 2014.
60. K. L. Chou, A. Lenhart, R. A. Koeppe, and N. I. Bohnen, "Abnormal MoCA and normal range MMSE scores in Parkinson disease without dementia: cognitive and neurochemical correlates," Parkinsonism & Related Disorders, vol. 20, no. 10, pp. 1076-1080, 2014.
61. J. Karlawish, M. Cary, S. T. Moelter et al., "Cognitive impairment and PD patients' capacity to consent to research," Neurology, vol. 81, no. 9, pp. 801-807, 2013.
62. L. Chen, C. Yu, X. Fu et al., "Using the Montreal Cognitive Assessment Scale to screen for dementia in Chinese patients with Parkinson's disease," Shanghai Archives of Psychiatry, vol. 25, no. 5, pp. 296-305, 2013.
63. K. Ohta, K. Takahashi, J. Gotoh et al., "Screening for impaired cognitive domains in a large Parkinson's disease population and its application to the diagnostic procedure for Parkinson's disease dementia," Dementia and Geriatric Cognitive Disorders Extra, vol. 4, pp. 147-159, 2014.
64. N. Kandiah, A. Zhang, A. R. Cenina, W. L. Au, N. Nadkarni, and L. C. Tan, "Montreal Cognitive Assessment for the screening and prediction of cognitive decline in early Parkinson's disease," Parkinsonism & Related Disorders, vol. 20, no. 11, pp. 1145-1148, 2014.
65. M. T. Hu, K. Szewczyk-Królikowski, P. Tomlinson et al., "Predictors of cognitive impairment in an early stage Parkinson's disease cohort," Movement Disorders, vol. 29, no. 3, pp. 351-359, 2014.